Purple biotech reports second quarter 2023 financial results

Financial results represent clinical trials progress with recruitment at a pace faster than expected in cm24 phase 2 study clinical data from both studies expected in the coming months cash runway extended into h1 2025
PPBT Ratings Summary
PPBT Quant Ranking